1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurological Diagnostic and Monitoring Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurological Diagnostic and Monitoring Equipment Market, North America
3.1 Neurological Diagnostic and Monitoring Equipment Market, North America, Revenue ($m), 2018-2033
3.2 Neurological Diagnostic and Monitoring Equipment Market, North America, Revenue ($m), 2018-2033
3.3 Neurological Diagnostic and Monitoring Equipment Market, North America, Volume (Units), 2018-2033
3.4 Neurological Diagnostic and Monitoring Equipment Market, North America, Volume (Units), 2018-2033
3.5 Neurological Diagnostic and Monitoring Equipment Market, North America, Company Share by Revenue ($m), 2023
4 Neurological Diagnostic and Monitoring Equipment Market, Canada
4.1 Neurological Diagnostic and Monitoring Equipment Market, Canada, Revenue ($m), 2018-2033
4.1.1 Electrical Activity Testing Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 ICP Monitoring Devices Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Neurological Diagnostic and Monitoring Equipment Market, Canada, Volume (Units), 2018-2033
4.2.1 Electrical Activity Testing Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 ICP Monitoring Devices Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Neurological Diagnostic and Monitoring Equipment Market, Canada, Average Price ($), 2018-2033
4.4 Neurological Diagnostic and Monitoring Equipment Market, Canada, Distribution Share by Revenue ($m), 2023
4.5 Neurological Diagnostic and Monitoring Equipment Market, Canada, Company Share by Revenue ($m), 2023
5 Neurological Diagnostic and Monitoring Equipment Market, Mexico
5.1 Neurological Diagnostic and Monitoring Equipment Market, Mexico, Revenue ($m), 2018-2033
5.1.1 Electrical Activity Testing Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 ICP Monitoring Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Neurological Diagnostic and Monitoring Equipment Market, Mexico, Volume (Units), 2018-2033
5.2.1 Electrical Activity Testing Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 ICP Monitoring Devices Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Neurological Diagnostic and Monitoring Equipment Market, Mexico, Average Price ($), 2018-2033
5.4 Neurological Diagnostic and Monitoring Equipment Market, Mexico, Distribution Share by Revenue ($m), 2023
5.5 Neurological Diagnostic and Monitoring Equipment Market, Mexico, Company Share by Revenue ($m), 2023
6 Neurological Diagnostic and Monitoring Equipment Market, United States
6.1 Neurological Diagnostic and Monitoring Equipment Market, United States, Revenue ($m), 2018-2033
6.1.1 Electrical Activity Testing Market, United States, Revenue ($m), by Segment, 2018-2033
6.1.2 ICP Monitoring Devices Market, United States, Revenue ($m), by Segment, 2018-2033
6.2 Neurological Diagnostic and Monitoring Equipment Market, United States, Volume (Units), 2018-2033
6.2.1 Electrical Activity Testing Market, United States, Volume (Units), by Segment, 2018-2033
6.2.2 ICP Monitoring Devices Market, United States, Volume (Units), by Segment, 2018-2033
6.3 Neurological Diagnostic and Monitoring Equipment Market, United States, Average Price ($), 2018-2033
6.4 Neurological Diagnostic and Monitoring Equipment Market, United States, Distribution Share by Revenue ($m), 2023
6.5 Neurological Diagnostic and Monitoring Equipment Market, United States, Company Share by Revenue ($m), 2023
7 Overview of Key Companies in North America Neurological Diagnostic and Monitoring Equipment Market
7.1 Natus Medical Inc
7.1.1 Company Overview
7.2 Nihon Kohden Corp
7.2.1 Company Overview
7.3 Medtronic Plc
7.3.1 Company Overview
7.4 Integra LifeSciences Corp
7.4.1 Company Overview
7.5 Masimo Corp
7.5.1 Company Overview
7.6 The Magstim Co Ltd
7.6.1 Company Overview
7.7 Cadwell Industries Inc
7.7.1 Company Overview
7.8 Raumedic AG
7.8.1 Company Overview
7.9 Moberg Research Inc
7.9.1 Company Overview
8 Neurological Diagnostic and Monitoring Equipment Market Pipeline Products
9 Recent Developments
9.1 Financial Announcements
9.1.1 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
9.1.2 Dec 04, 2024: NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
9.1.3 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
9.1.4 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
9.2 Government and Public Interest
9.2.1 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
9.3 Product News
9.3.1 Dec 17, 2024: Adnexus Biotechnologies Unveils Neural Temporal Fingerprinting for Personalized Health Monitoring Using Artificial Intelligence
9.3.2 Oct 03, 2024: Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
9.3.3 Aug 23, 2024: New Study Lights Path for Early Detection of Schizophrenia and Other Psychotic Disorders
9.3.4 Mar 25, 2024: A study led by IBEC successfully mimics the complex neuroblastoma vasculature on a chip to explore treatments for this pediatric cancer
9.4 Strategy And Business Planning
9.4.1 Jan 14, 2025: Neurogen Biomarking Launches Collaboration With Linus Health
9.4.2 Oct 29, 2024: Brook Health and Linus Health Revolutionize Cognitive Care: Same-Day Assessment and Treatment Now a Reality
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer